Mini-review of three high yield NRTI mutations from rounds today -- Keep scrolling for more!
🧬🧬M184V🧬🧬
💠selected by Emtricitabine (FTC), Lamivudine (3TC)
💠High resistance to: FTC/3TC
⬇️viral fitness
⬆️susceptibility tenofovir (TDF/TAF), zidovudine (AZT)
💠Pt may stay on FTC or 3TC with M184V in order to maintain ⬇️fitness + hypersusceptibility to TAF/TDF
🧬🧬K65R🧬🧬
💠selected by TDF/TAF
💠High resistance to tenofovir; cross-class resistance except for AZT
⬆️AZT susceptibility
⬇️viral fitness*
*additive with M184C
🧬🧬TAMs (thymidine analogue mutations)🧬🧬
💠2 pathways
(1) M41L, L210W, T215F/Y
(2) D67N, K70R, K219Q
💠selected by AZT, Stavudine (d4T)
⬇️all NRTIs. Type 1 has greater impact on tenofovir